GeneDx Holdings (WGS) Treasury Shares (2020 - 2021)

GeneDx Holdings (WGS) has reported Treasury Shares for 7 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Treasury Shares fell 8.06% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (down 8.06% YoY), while the FY2025 annual figure was $1.5 million, down 18.71% from the prior year.
• Treasury Shares climbed to $1.7 million in Q1 2026 per WGS's latest filing, from $1.5 million in the prior quarter.
• Across five years, Treasury Shares topped out at $23.7 million in Q3 2022 and bottomed at $855061.0 in Q4 2022.
• Historically, Treasury Shares has averaged $4.9 million across 5 years, with a median of $1.8 million in 2025.
• Annual changes were most pronounced in 2022 — Treasury Shares tumbled 93.21% — and 2023, when it jumped 76.35%.
• GeneDx Holdings' Treasury Shares stood at $855061.0 in 2022, then surged by 76.35% to $1.5 million in 2023, then increased by 23.99% to $1.9 million in 2024, then dropped by 18.71% to $1.5 million in 2025, then gained by 8.72% to $1.7 million in 2026.
• Business Quant data shows WGS's Treasury Shares at $1.7 million in Q1 2026, $1.5 million in Q4 2025, and $1.6 million in Q3 2025.